Author: Andrew Owen
- ORCiD: http://orcid.org/0000-0002-9819-7651
- Most recently observed institution: Institute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom
Rankings
- All-time downloads: 39,358 (rank: 6,224 )
- Categories:
- genetics: 299 (rank: 40,011 (tie) )
- immunology: 1,478 (rank: 10,447 (tie) )
- infectious diseases: 5,245 (rank: 11,487 )
- microbiology: 15,808 (rank: 1,386 (tie) )
- pathology: 1,182 (rank: 1,413 (tie) )
- pharmacology and therapeutics: 9,585 (rank: 43 (tie) )
- pharmacology and toxicology: 2,059 (rank: 671 (tie) )
- respiratory medicine: 601 (rank: 1,736 (tie) )
Downloads per author, site-wide
Preprints
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
microbiology more details view paper- Downloaded 6,658 times
- Download rankings, all-time:
- Site-wide: 2,153
- In microbiology: 192
- Year to date:
- Site-wide: 199
- Since beginning of last month:
- Site-wide: 3,234
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
pharmacology and therapeutics more details view paper- Downloaded 4,850 times
- Download rankings, all-time:
- Site-wide: 3,303
- In pharmacology and therapeutics: 9
- Year to date:
- Site-wide: 29,285
- Since beginning of last month:
- Site-wide: 54,926
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
pharmacology and therapeutics more details view paper- Downloaded 4,458 times
- Download rankings, all-time:
- Site-wide: 3,710
- In pharmacology and therapeutics: 11
- Year to date:
- Site-wide: 2,170
- Since beginning of last month:
- Site-wide: 6,070
Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2
microbiology more details view paper- Downloaded 3,855 times
- Download rankings, all-time:
- Site-wide: 4,537
- In microbiology: 294
- Year to date:
- Site-wide: 25,478
- Since beginning of last month:
- Site-wide: 50,777
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
infectious diseases more details view paper- Downloaded 3,295 times
- Download rankings, all-time:
- Site-wide: 5,705
- In infectious diseases: 1,085
- Year to date:
- Site-wide: 42,055
- Since beginning of last month:
- Site-wide: 38,721
The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
microbiology more details view paper- Downloaded 2,696 times
- Download rankings, all-time:
- Site-wide: 7,615
- In microbiology: 450
- Year to date:
- Site-wide: 46,118
- Since beginning of last month:
- Site-wide: 43,275
Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19.
microbiology more details view paper- Downloaded 1,898 times
- Download rankings, all-time:
- Site-wide: 12,834
- In microbiology: 758
- Year to date:
- Site-wide: 23,609
- Since beginning of last month:
- Site-wide: 49,275
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice
immunology more details view paper- Downloaded 1,513 times
- Download rankings, all-time:
- Site-wide: 18,093
- In immunology: 617
- Year to date:
- Site-wide: 66,114
- Since beginning of last month:
- Site-wide: 104,273
Neuroinvasion and neurotropism by SARS-CoV-2 variants in the K18-hACE2 mouse
pathology more details view paper- Downloaded 1,401 times
- Download rankings, all-time:
- Site-wide: 20,359
- In pathology: 106
- Year to date:
- Site-wide: 11,655
- Since beginning of last month:
- Site-wide: 12,024
Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
infectious diseases more details view paper- Downloaded 1,169 times
- Download rankings, all-time:
- Site-wide: 26,948
- In infectious diseases: 2,510
- Year to date:
- Site-wide: 107,680
- Since beginning of last month:
- Site-wide: 93,948
Development of a highly sensitive bioanalytical assay for the quantification of favipiravir.
pharmacology and toxicology more details view paper- Downloaded 993 times
- Download rankings, all-time:
- Site-wide: 34,489
- In pharmacology and toxicology: 214
- Year to date:
- Site-wide: 23,869
- Since beginning of last month:
- Site-wide: 15,535
Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351
microbiology more details view paper- Downloaded 830 times
- Download rankings, all-time:
- Site-wide: 44,968
- In microbiology: 2,603
- Year to date:
- Site-wide: 91,341
- Since beginning of last month:
- Site-wide: 59,600
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2
infectious diseases more details view paper- Downloaded 798 times
- Download rankings, all-time:
- Site-wide: 47,609
- In infectious diseases: 3,503
- Year to date:
- Site-wide: 38,971
- Since beginning of last month:
- Site-wide: 53,133
An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2
pharmacology and therapeutics more details view paper- Downloaded 712 times
- Download rankings, all-time:
- Site-wide: 55,953
- In pharmacology and therapeutics: 64
- Year to date:
- Site-wide: 68,909
- Since beginning of last month:
- Site-wide: 63,825
TITLE: Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
respiratory medicine more details view paper- Downloaded 669 times
- Download rankings, all-time:
- Site-wide: 61,212
- In respiratory medicine: 135
- Year to date:
- Site-wide: 35,859
- Since beginning of last month:
- Site-wide: 43,709
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants.
microbiology more details view paper- Downloaded 618 times
- Download rankings, all-time:
- Site-wide: 67,882
- In microbiology: 4,036
- Year to date:
- Site-wide: 109,616
- Since beginning of last month:
- Site-wide: 102,372
Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters
pharmacology and toxicology more details view paper- Downloaded 589 times
- Download rankings, all-time:
- Site-wide: 72,102
- In pharmacology and toxicology: 507
- Year to date:
- Site-wide: 32,084
- Since beginning of last month:
- Site-wide: 26,306
Lack of Ronapreve (REGN-CoV; casirivimab and imdevimab) virological efficacy against the SARS-CoV 2 Omicron variant (B.1.1.529) in K18-hACE2 mice
microbiology more details view paper- Downloaded 577 times
- Download rankings, all-time:
- Site-wide: 74,098
- In microbiology: 7,654
- Year to date:
- Site-wide: 4,088
- Since beginning of last month:
- Site-wide: 29,367
Optimisation and validation of a sensitive bioanalytical method for niclosamide.
pharmacology and toxicology more details view paper- Downloaded 526 times
- Download rankings, all-time:
- Site-wide: 82,743
- In pharmacology and toxicology: 590
- Year to date:
- Site-wide: 40,790
- Since beginning of last month:
- Site-wide: 29,911
N-acetyltransferase 2 genotypes amongst ulu Speaking South Africans and isoniazid / N-acetyl-isoniazid pharmacokinetics during ant-tuberculosis treatment
genetics more details view paper- Downloaded 320 times
- Download rankings, all-time:
- Site-wide: 132,657
- In genetics: 4,970
- Year to date:
- Site-wide: 121,338
- Since beginning of last month:
- Site-wide: 122,805
Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19
infectious diseases more details view paper- Downloaded 275 times
- Download rankings, all-time:
- Site-wide: 145,969
- In infectious diseases: 6,908
- Year to date:
- Site-wide: 12,598
- Since beginning of last month:
- Site-wide: 36,136
Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.
pharmacology and toxicology more details view paper- Downloaded 274 times
- Download rankings, all-time:
- Site-wide: 146,242
- In pharmacology and toxicology: 1,127
- Year to date:
- Site-wide: 91,326
- Since beginning of last month:
- Site-wide: 56,745
Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study
pharmacology and therapeutics more details view paper- Downloaded 194 times
- Download rankings, all-time:
- Site-wide: 168,461
- In pharmacology and therapeutics: None
- Year to date:
- Site-wide: 21,051
- Since beginning of last month:
- Site-wide: 3,104
Lack of antiviral activity of probenecid in Vero E6 cells and Syrian golden hamsters: a need for better understanding of inter-lab differences in preclinical assays.
pharmacology and toxicology more details view paper- Downloaded 190 times
- Download rankings, all-time:
- Site-wide: 169,607
- In pharmacology and toxicology: None
- Year to date:
- Site-wide: 21,685
- Since beginning of last month:
- Site-wide: 48,374
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!